bile duct stricture

bile duct stricture

An abnormal narrowing of the common bile duct due to local scarring, which may cause biliary obstruction.
 
Clinical findings
Jaundice, fever, chills, abdominal pain.
 
Aetiology
Prior local surgery, pancreatitis, trauma, gallstones.

Management
 Endoscopic surgery with insertion of self-expanding metal mesh stents.

bile duct stricture

Biliary stricture Surgery An abnormal narrowing of the common bile duct, due to local scarring, which may cause biliary obstruction Etiology Prior local surgery, pancreatitis, trauma, gallstones Clinical Jaundice, fever, chills, abdominal pain Management Endoscopic surgery
References in periodicals archive ?
The patient subsequently underwent endoscopic retrograde cholangiopancreatography (ERCP) showing a distal common bile duct stricture.
Regardless of modality, a lengthy segment of extrahepatic bile duct stricture with irregular margin and asymmetric narrowing suggests cholangiocarcinoma, while a short segment with regular margin and symmetric narrowing supports a benign cause.
9) The yield of cytology is not improved with stricture dilation, but repeated brush cytology attempts of a bile duct stricture will increase the tissue yield.
Results of endoscopic ultrasound in 30 patients Diagnosis Number (percentage) Choledocholithiasis 9 (30%) Microlithiasis/biliary sludge 11 (37%) Pancreatitis 8 (27%) Cholelithiasis 7 (23%) Other * 4 (13%) No abnormalities 3 (10%) * Common bile duct stricture (2 patients), pancreas divisum, pseudocyst.
Abstract: Biliary obstruction due to a proximal bile duct stricture is commonly a result of cholangiocarcinoma.
Endoscopic retrograde cholangiopancreatography showed a short distal common bile duct stricture with dilatation proximal to the stricture.
8) Advanced cytologic and molecular markers have been described for patients with bile duct strictures that are felt to increase the sensitivity and specificity in diagnosing malignancy over routine cytology.
18, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has completed enrollment in a clinical trial to evaluate its WallFlex Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures (narrowing or blockages).
Results from a published study of patients with post-operative benign bile duct strictures demonstrated that stenting has similar long-term success rates and lower early complication rates compared to surgery[1].
announced the European availability of the WallFlex Biliary RX Stent for the treatment of malignant common bile duct strictures.
Pancreatic pseudocysts, chronic pancreatitis, sclerosing cholangitis, benign bile duct strictures or parasites in the bile duct are less common causes.
Biliary drainage procedures are indicated for a variety of conditions, including benign biliary strictures occurring after cholecystectomy, distal common bile duct strictures secondary to chronic pancreatitis, primary sclerosing cholangitis and malignancies.